Authors


Kimberly Martin, RN

Latest:

Benefits of Early Pharmacological Treatment in Alzheimer Disease

Successful intervention for Alzheimer disease requires an early and timely diagnosis. Caregivers of persons with AD often state that an average of 2 years passes from the onset of symptoms to a formal diagnosis.


Kimberly Young, PsyD

Latest:

Video Games: Recreation or Addiction?

Many people like to spend at least part of their free time playing video games. However, for some, what starts as innocent recreation becomes an addiction and, at times, tragedy ensues.


Kiran Rabheru, MD

Latest:

Depression in Dementia: Diagnosis and Treatment

It has been well established that there is a high incidence of depression in conjunction with Alzheimer's disease and other forms of dementia. What are the best assessment and diagnostic methods, and which treatments will produce the best results?


Kirandeep K. Somal, MD

Latest:

Referral Strategies for Patients With Co-Occurring Substance Use and Psychiatric Disorders

This article provides an overview of research concerning referral strategies for patients with substance use disorder and co-occurring disorders in the emergency department.


Kirk Heilbrun, PhD

Latest:

Forced Medication and Competency to Stand Trial: Clinical, Legal, and Ethical Issues

The authors examine legal and ethical challenges for the psychiatrist when a defendant who is incompetent to stand trial declines to take prescribed psychotropic medication.


Kirk J. Brower, MD

Latest:

The Legacy of Suicide

A personal account of a psychiatrist whose brother died by suicide.


Kiwon Lee, MD

Latest:

Edema Associated With Infarct . . . Or Something Else?

A sharp decrease in visual acuity affecting both eyes developed in a 35-year-old man 3 days after elective abdominal surgery. Six months earlier, acute B cell-type lymphoblastic leukemia was diagnosed in the patient for which he received bone marrow transplantation (BMT). Following BMT, graft-versus-host disease developed in the patient. It was treated with cyclosporine, mycophenolate mofetil (CellCept), sirolimus (Rapamune), and prednisone.


Kolleen H. Fox, PhD

Latest:

Cognitive Impairment in Patients With Bipolar Disorder

It is widely accepted that patients with schizophrenia have some degree of cognitive deficiency and that cognitive deficits are an inherent part of the disorder. Historically, there has been less focus on cognitive deficits in patients with bipolar disorder; however, numerous studies of cognition in patients with bipolar disorder, including several comprehensive meta-analyses of bipolar patients who were euthymic at the time of testing, have recently been undertaken.1-4 Each of these analyses found that cognitive impairment persists during periods of remission, mainly in domains that include attention and processing speed, memory, and executive functioning.4


Konrad Talbot, PhD

Latest:

Brain Insulin Resistance in Alzheimer Disease and Its Potential Treatment With a Mediterranean Diet and GLP-1 Analogues

This article explains the rationale and evidence for 2 novel treatments of Alzheimer disease: a reformulated Mediterranean diet and an antidiabetic agent, liraglutide, marketed as Victoza.


Kostas N. Fountoulakis, MD, PhD

Latest:

A Critical Consideration of the Most Recent Guidelines for Bipolar Depression

This article reviews the most recent (after 2010) published guidelines on bipolar depression.


Kris Bifulco, MPH

Latest:

Youth-Led Suicide Prevention in an Indigenous Rural Community

Suicide is a pervasive public health issue for adolescents in Hawaii. In response, a youth leadership model was initiated to empower young leaders in suicide prevention through evidence-based training, relationship building, and community awareness.


Kristalyn Salters-pedneault, PhD

Latest:

Strategies for Assessing and Treating Comorbid Panic and Generalized Anxiety Disorder

The 2 most common anxiety disorders are generalized anxiety disorder (GAD) and panic disorder. Approximately 5.7% of people in community samples will meet diagnostic criteria for GAD in their lifetime; the rate is about 4.7% for panic disorder (with or without agoraphobia).1 GAD-which is characterized by excessive and uncontrollable worry about a variety of topics (along with associated features such as trouble sleeping and impaired concentration)-is often chronic and is associated with significant costs to the individual and to society.


Kristen K. Ellard, MA

Latest:

Development of a Transdiagnostic Unified Psychosocial Treatment for Emotional Disorders

Research emerging from the field of emotion science suggests that individuals who have anxiety and mood disorders tend to experience negative affect more frequently and more intensely than do healthy individuals, and they tend to view these experiences as more aversive, representing a common diathesis across anxiety and mood disorders.1-5 Deficits in the ability to regulate emotional experiences, resulting from unsuccessful efforts to avoid or dampen the intensity of uncomfortable emotions, have also been found across the emotional disorders and are a key target for therapeutic change.


Kristen Lambert, JD, MSW

Latest:

New Risks to Confidentiality in the Modern Era

While this article highlights some of the modern-era risks to confidentiality that psychiatrists may experience, it does not constitute an exhaustive list of issues to consider and is not a substitute for legal advice.


Kristen Schmidt, MD

Latest:

Mini Quiz: Alcohol and Sleep

Which sleep parameters are increased in alcohol use disorders? Take the quiz and learn more.


Kristi Estabrook, MD

Latest:

A “Real” Psychiatrist

As the end of this psychiatrist's intern year approached, a chief resident told her that second year is the year “you really become a psychiatrist.”


Kristi R. Estabrook, MD

Latest:

Hypothyroidism: An Important Diagnostic Consideration for the Psychiatrist

Hypothyroidism is a common clinical disorder that psychiatrists frequently encounter. However, symptoms of thyroid dysfunction are often vague and nonspecific, which can lead to delayed or missed diagnosis.


Kryst Cedeño

Latest:

The Role of Psychiatrists in Countering Violent Extremism

There is no predictive tool that is likely to have validity for rare outcomes such as terrorist attacks. More here.


Kuan-pin Su, MD

Latest:

The Use of Omega-3 Fatty Acids in Treatment of Depression

This review provides an overview of the efficacy, safety, and mechanisms of action in the treatment of depression.


Kyleeann Stevens, MD

Latest:

Handbook of Correctional Mental Health, Second Edition

With the transition of patients with mental illness from the beds of psychiatric institutions into the community the need for knowledgeable mental health professionals continues to grow. Correctional psychiatry has evolved in recent years and presents special challenges for clinicians, which this handbook deftly addresses. Contributing authors with various backgrounds provide a broad range of expertise.


KyoungBin Im, MD, MS

Latest:

Obstructive Sleep Apnea and Depression: Issues for Psychiatrists

What are the effects of sleep apnea on depression--and depression on sleep apnea? Insights here.


Kyrie Shomaker, MD

Latest:

What's New in Pediatric Lower Respiratory Tract Infections?

Lower respiratory tract infections are among the most frequent causes for office visits and hospitalizations of otherwise healthy young US children. Here, an overview of current guidance on diagnosis and management.


L. Jaime Fitten, MD

Latest:

Older Drivers Revisited

The United States is facing accelerated growth in the number of older citizens due to the aging baby boomer generation. It is expected that this emerging cohort will have more licensed drivers who will drive longer distances more frequently and later into life than preceding generations. What are the risks from elderly drivers and how can we help them drive safely?


L. P. Voruganti, MD, PhD

Latest:

Medications and Quality of Life With Schizophrenia

The expression "quality of life" is an intuitively familiar and popular concept, and it epitomizes the public's hopes and expectations. In clinical settings, it demands the inclusion of patients' feelings, attitudes, and opinions in medical decision making.


Laili Soleimani, MD

Latest:

Does Ketamine Hold Promise in Mitigating Suicide Risk?

The authors review mechanisms of suicide and the effectiveness of current treatments, and zero in on ketamine--a potential novel, rapidly acting treatment for suicidality.


Lakshmi N. Ravindran, MD

Latest:

Tips for Treating Comorbid Depression and Anxiety

Comorbid depressive and anxiety disorders are commonly seen in both primary care and the specialty setting. Such comorbidity can present as major depression with subsyndromal anxiety symptoms or unipolar/bipolar depression with an anxiety disorder.


Lama Bazzi, MD

Latest:

Survived by One: The Life and Mind of a Family Mass Murderer

There are many stories written about serial killers and murderers, books that narrate the life course of individuals who commit heinous acts. However, few have been written by murderers explaining their lives first-hand.


Lara Gayle Chepenik, MD, PhD

Latest:

Working With Physicians in the Emergency Department

It is not surprising that one of the most complicated aspects of collaboration with faculty and staff in the ED setting is the professional or social contract.


Larry Brooks, PhD

Latest:

Mobile Apps for Mental Health

Here: a look at Mobilyze and CrossCheck--2 apps currently in development that are embedded within smartphones and designed to capture objective data on patients to provide timely treatment and relapse prevention.


Larry D. Alphs, PhD

Latest:

5 Domains of Negative Symptoms of Schizophrenia

Negative symptoms identified from the Negative Symptom Assessment and the behaviors that might be observed in each of 5 domains.

© 2024 MJH Life Sciences

All rights reserved.